Home › Neuroblastoma › Hawaii › Honolulu
Neuroblastoma clinical trials in Honolulu, HI
6 studies for Neuroblastoma are looking for participants at sites in and around Honolulu (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Kapiolani Medical Center for Women and Children, Honolulu
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RecruitingPhase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RecruitingPhase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RecruitingPhase 2
- Kapiolani Medical Center for Women and Children, Honolulu
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
- Aurora, CO8 studies
- Hartford, CT8 studies
- Minneapolis, MN8 studies
- Birmingham, AL8 studies
- Atlanta, GA7 studies
Other studies in Honolulu
- Cancer (all types)13 studies
- Obesity13 studies
- Breast Cancer12 studies
- Overweight11 studies
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Type 2 Diabetes7 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer5 studies
- Burkitt Lymphoma5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.